Email this LII item:
FDA Takes Action on Plan B
August 26, 2005, statement by Food and Drug Administration (FDA) Commissioner Lester M. Crawford about FDA decision-making processes relating to whether Plan B contraceptives, also known as morning-after pills, should be available without a prescription. The statement gives an overview of the issues being considered by the FDA and discusses the need for additional evaluation.
http://www.fda.gov/ScienceResearch/SpecialTopics/WomensHealthResearch/ucm134343.htm
Asterisk
*
indicates required field.
Your Name
*
Your Email Address
*
Recipient Email Address(es)
*
(separate multiple addresses with commas)
Message
Enter the verification code as it is shown in the box below. This helps prevent automated submissions.
*
